Radiation Therapy Effective Against AIDS-related Head and Neck Cancer

In a recent study it has been highlighted that HIV-positive head and neck cancer patients respond well to radiation therapy treatments.

In a recent study it has been highlighted that HIV-positive head and neck cancer patients respond well to radiation therapy treatments and experience similar toxicity rates as non-HIV-positive patients.

Patients with HIV have a significantly higher risk of developing some types of cancers; however, since the use of highly active antiretroviral therapy (HAART) began in the mid-1990s, the instances of AIDS-related cancer have greatly decreased. This has alternately caused a higher incidence of these patients developing non-AIDS-related cancers, including those originating from the head and neck.

Study on the Speech/swallowing Problems Post Treatment of Head and Neck Cancers
Researchers at the Duke Cancer Institute said that most victims of locally advanced head and neck cancers successfully complete treatment without losing the ability to speak or swallow.

Radiation therapy constitutes a current standard treatment for head and neck cancer, but there has been very little investigation into how radiation therapy affects HIV-positive patients. Traditionally, aggressive treatment such as radiation therapy has been used sparingly in this population due to concerns regarding acute and late complications. This newly presented research sought to determine the feasibility of radiation therapy and the likelihood of cure for HIV-positive patients with head and neck cancer.

The three-year estimates of overall survival and local-regional control were 78 percent and 92 percent, respectively. Grade 3+ toxicity was reported by 58 percent of patients, but this did not appear worse than the standard rate seen in HIV-negative patients.

The researchers did note that 75 percent of patients studied were receiving HAART therapy at the time of treatment. Also, all patients underwent dental prophylaxis and gastrostomy tube placement before beginning therapy, which may have played a role in the toxicity levels remaining comparable to HIV-negative patients. Dental prophylaxis, gastrostomy tubes, and monitoring of CD4 counts are recommended in these patients to minimize treatment complications.

Quiz on Cancer
Cancer, is the second most leading cause of death worldwide. Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Take this quiz on and test how much you know about cancer.

"It is clear that HIV-positive patients tolerated primary radiation therapy for head-and-neck cancer without excessive toxicity or exaggerated tissue reactions," Allen Chen, M.D., senior author of the study and training program director at the University of California Davis Cancer Center in Sacramento, California, said. "With HIV-positive patients living longer than ever before and therefore developing cancers unrelated to their HIV, these studies are important to ensure that we are treating these patients for cancer in a way that provides them with the best possible outcomes."

Source-Eurekalert

Cancer Pain - Causes - Effects - Assessment - Treatment - FAQs - Video
Every 1 out of 3 people undergoing cancer treatment experiences pain.

Robotic Surgery For Head And Neck Cancers Effective
Less-invasive robotic surgery for head and neck cancers is as effective as other minimally invasive surgical techniques according to University of Alabama at Birmingham researchers.